Effect of prednisone on nephrotic peripheral blood mononuclear cell mediated increase in 35sulfate uptake in rat

E H Garin1

  • 1Department of Pediatrics, Medical University of South Carolina, Charleston.

Nephron
|January 1, 1989
PubMed

Insights

Prednisone therapy reversed increased glomerular basement membrane sulfate uptake caused by peripheral blood mononuclear cells in patients with idiopathic minimal-lesion nephrotic syndrome. This suggests a link between GBM sulfate metabolism and proteinuria.

Area of Science:

  • Nephrology
  • Immunology
  • Biochemistry

Background:

  • Idiopathic minimal-lesion nephrotic syndrome (IMLNS) is characterized by proteinuria and effacement of podocyte foot processes.
  • Peripheral blood mononuclear cells (PBMC) from IMLNS patients in relapse significantly increase 35sulfate uptake in rat glomerular basement membrane (GBM).
  • This effect is absent in PBMC from IMLNS patients in remission or on prednisone therapy.

Purpose of the Study:

  • To investigate the effect of prednisone therapy on PBMC-mediated 35sulfate uptake in rat GBM.
  • To explore the role of GBM sulfated compounds in glomerular permeability.
  • To support the hypothesis that PBMC-derived lymphokines alter GBM metabolism in IMLNS.

Main Methods:

  • Coculturing rat glomeruli with PBMC from IMLNS patients in relapse and remission.
  • Measuring 35sulfate uptake in GBM.
  • Comparing GBM sulfate uptake in glomeruli cultured alone versus with PBMC, before and during prednisone treatment.

Main Results:

  • GBM 35sulfate uptake was significantly higher when cocultured with PBMC from IMLNS patients in relapse compared to glomeruli cultured alone.
  • Prednisone therapy abolished the PBMC-mediated increase in GBM 35sulfate uptake.
  • No significant difference in GBM 35sulfate uptake was observed with PBMC from patients on prednisone or in remission.

Conclusions:

  • Prednisone therapy effectively inhibits the PBMC-induced increase in GBM 35sulfate uptake.
  • GBM sulfated compounds are implicated in regulating glomerular permeability.
  • PBMC from relapsed IMLNS patients may secrete lymphokines that increase glomerular permeability by altering GBM sulfated compound metabolism.

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...